These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 18085732
1. Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis. Kotani T, Makino S, Takeuchi T, Kagitani M, Shoda T, Hata A, Tabushi Y, Hanafusa T. J Rheumatol; 2008 Feb; 35(2):254-9. PubMed ID: 18085732 [Abstract] [Full Text] [Related]
2. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M, Amano K, Takeuchi T. J Rheumatol; 2005 Sep; 32(9):1719-26. PubMed ID: 16142867 [Abstract] [Full Text] [Related]
3. Combination with corticosteroids and cyclosporin-A improves pulmonary function test results and chest HRCT findings in dermatomyositis patients with acute/subacute interstitial pneumonia. Kotani T, Takeuchi T, Makino S, Hata K, Yoshida S, Nagai K, Wakura D, Shoda T, Hanafusa T. Clin Rheumatol; 2011 Aug; 30(8):1021-8. PubMed ID: 21340495 [Abstract] [Full Text] [Related]
4. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases]. Harigai M, Hara M, Kamatani N, Kashiwazaki S. Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405 [Abstract] [Full Text] [Related]
5. Therapeutic drug monitoring of cyclosporine microemulsion in interstitial pneumonia with dermatomyositis. Nagai K, Takeuchi T, Kotani T, Hata K, Yoshida S, Isoda K, Fujiki Y, Shiba H, Makino S, Hanafusa T. Mod Rheumatol; 2011 Feb; 21(1):32-6. PubMed ID: 20680374 [Abstract] [Full Text] [Related]
6. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I. J Rheumatol; 1999 Jul; 26(7):1527-33. PubMed ID: 10405940 [Abstract] [Full Text] [Related]
7. Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a/glucocorticosteroid combination therapy: a case control study [corrected]. Isoda K, Takeuchi T, Kotani T, Hata K, Shoda T, Ishida T, Yoshida S, Kimura Y, Makino S, Hanafusa T. PLoS One; 2014 Jul; 9(2):e89610. PubMed ID: 24586910 [Abstract] [Full Text] [Related]
8. [Therapeutic efficacy of cyclosporin A in four cases of amyopathic dermatomyositis with rapidly progressive interstitial pneumonia]. Ozawa Y, Kurosaka D, Yokoyama T, Tajima N. Ryumachi; 2000 Oct; 40(5):798-809. PubMed ID: 11215158 [Abstract] [Full Text] [Related]
9. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy. Carstens J. Scand J Urol Nephrol; 2008 Oct; 42(3):286-92. PubMed ID: 18432535 [Abstract] [Full Text] [Related]
10. [A case of dermatomyositis complicated with pneumomediastinum that was successfully treated with cyclosporin A]. Nonomura Y, Koike R, Nishio J, Tsubata R, Kohsaka H, Kubota T, Miyasaka N. Ryumachi; 2001 Jun; 41(3):653-8. PubMed ID: 11505515 [Abstract] [Full Text] [Related]
12. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M, Uchiyama H, Tamura R, Ida M, Yagi T, Yasuda K, Genma H, Hayakawa H, Chida K, Nakamura H. J Rheumatol; 2005 Jan; 32(1):58-64. PubMed ID: 15630726 [Abstract] [Full Text] [Related]
14. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients. Paydaş S, Balal M, Sertdemir Y, Seyrek N, Karayaylali I. Ren Fail; 2005 Jan; 27(4):409-13. PubMed ID: 16060128 [Abstract] [Full Text] [Related]
15. [Cyclosporin treatment of interstitial pneumonia and monitoring of serum concentration]. Enomoto N, Suda T, Hashimoto D, Naito T, Fujisawa T, Miwa S, Nakano H, Suzuki K, Yokomura K, Ide K, Chida K. Nihon Kokyuki Gakkai Zasshi; 2004 Nov; 42(11):934-40. PubMed ID: 15651272 [Abstract] [Full Text] [Related]
17. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis. Ieiri I, Nakayama J, Murakami H, Hori Y, Higuchi S. Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088 [Abstract] [Full Text] [Related]
18. [Clinicopathological features of interstitial pneumonia associated with amyopathic dermatomyositis]. Toyoshima M, Sato A, Chida K, Hayakawa H, Todate A, Imokawa S, Iwata M, Ohashi H, Shirai M, Yagi H. Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Mar; 35(3):281-7. PubMed ID: 9168643 [Abstract] [Full Text] [Related]
19. Efficacy and safety of oral high-trough level tacrolimus in acute/subacute interstitial pneumonia with dermatomyositis. Suzuka T, Kotani T, Takeuchi T, Fujiki Y, Hata K, Yoshida S, Shoda T, Makino S, Arawaka S. Int J Rheum Dis; 2019 Feb; 22(2):303-313. PubMed ID: 30398034 [Abstract] [Full Text] [Related]
20. Polymyositis/dermatomyositis and interstitial lung disease: a new therapeutic approach with T-cell-specific immunosuppressants. Takada K, Nagasaka K, Miyasaka N. Autoimmunity; 2005 Aug; 38(5):383-92. PubMed ID: 16227154 [Abstract] [Full Text] [Related] Page: [Next] [New Search]